OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of RIPK3‐regulated cell death pathways and necroptosis in the pathogenesis of cardiac ischaemia‐reperfusion injury
Ying Luo, Juthipong Benjanuwattra, Siriporn C. Chattipakorn, et al.
Acta Physiologica (2020) Vol. 231, Iss. 2
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review)
Jianfeng He, Danyong Liu, Lixia Zhao, et al.
Experimental and Therapeutic Medicine (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 148

Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia/reperfusion injury by interacting with NAMPT
Jie Ju, Xinmin Li, Xuemei Zhao, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 60

Crosstalk between metabolism and cell death in tumorigenesis
Shichao Yang, Caden Hu, Xiaomei Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27

Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: Cumulative evidence for future cardioprotective strategies
Panat Yanpiset, Chayodom Maneechote, Sirawit Sriwichaiin, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 1, pp. 29-53
Open Access | Times Cited: 45

Programmed cardiomyocyte death in myocardial infarction
Hao Wu, Qi Lan, Yi-Xiang He, et al.
APOPTOSIS (2025)
Closed Access | Times Cited: 1

Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis
Thawatchai Khuanjing, Benjamin Ongnok, Chayodom Maneechote, et al.
Pharmacological Research (2021) Vol. 173, pp. 105882-105882
Closed Access | Times Cited: 46

Targeting necroptosis as therapeutic potential in chronic myocardial infarction
Chanon Piamsiri, Chayodom Maneechote, Natthaphat Siri‐Angkul, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 41

Role of Necroptosis and Immune Infiltration in Human Stanford Type A Aortic Dissection: Novel Insights from Bioinformatics Analyses
Fuqiang Liu, Tao Wei, Lin Liu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 27

The potential role and mechanism of circRNAs in Ferroptosis: A comprehensive review
Javad Arabpour, Kimia Rezaei, Javad Yaghmoorian Khojini, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155203-155203
Closed Access | Times Cited: 6

Pharmaceutical Therapies for Necroptosis in Myocardial Ischemia–Reperfusion Injury
Yinchang Zhang, Yantao Zhang, Jinlong Zang, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 7, pp. 303-303
Open Access | Times Cited: 10

Regulatory mechanism of CaMKII δ mediated by RIPK3 on myocardial fibrosis and reversal effects of RIPK3 inhibitor GSK'872
Jingjing Zhang, Ji Cao, Jianan Qian, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115380-115380
Open Access | Times Cited: 10

Necroptosis in myocardial ischaemia-reperfusion injury: current update on mechanisms, therapeutic targets, and translational potential
Siarhei A. Dabravolski, Vladislav Kalmykov, Anastasia O Maksaeva, et al.
APOPTOSIS (2025)
Closed Access

Supramolecular Self-Assembled Nanofibers Efficiently Activate the Precursor of Hepatocyte Growth Factor for Angiogenesis in Myocardial Infarction Therapy
Wenjie Guo, Weijing Feng, Jing Huang, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 19, pp. 22131-22141
Closed Access | Times Cited: 23

Hydrogen sulfide protects against ischemic heart failure by inhibiting RIP1/RIP3/MLKL-mediated necroptosis
Fengwang Ma, Yi Zhun Zhu, Lingling Chang, et al.
Physiological Research (2022) Vol. 71, Iss. 6, pp. 771-781
Open Access | Times Cited: 16

Role of necroptosis and immune infiltration in preeclampsia: novel insights from bioinformatics analyses
Lidan He, Feng Zhan, Lin Lu, et al.
BMC Pregnancy and Childbirth (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9

Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
Thawatchai Khuanjing, Chayodom Maneechote, Benjamin Ongnok, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 9

Protective effects of necrostatin-1 on doxorubicin-induced cardiotoxicity in rat heart
Zeynep Erdoğmuş Özgen, Meral Erdinç, İlker Kelle, et al.
Human & Experimental Toxicology (2022) Vol. 41
Open Access | Times Cited: 14

Inhibition of myeloid differentiation factor 2 attenuates cardiometabolic impairments via reducing cardiac mitochondrial dysfunction, inflammation, apoptosis and ferroptosis in prediabetic rats
Natticha Sumneang, Thura Tun Oo, Kodchanan Singhanat, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1868, Iss. 2, pp. 166301-166301
Open Access | Times Cited: 15

The Bcr-Abl inhibitor DCC-2036 inhibits necroptosis and ameliorates osteoarthritis by targeting RIPK1 and RIPK3 kinases
Longhuan Piao, Wu Dong, Chunhua Rui, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114528-114528
Open Access | Times Cited: 6

Succinate pretreatment attenuates intestinal ischemia-reperfusion injury by inhibiting necroptosis and inflammation via upregulating Klf4
Zhen Cao, Silong Mu, Maihuan Wang, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110425-110425
Closed Access | Times Cited: 6

Dexmedetomidine as a myocardial protector in pediatric heart surgery using cardiopulmonary bypass: a systematic review
Dian Kesumarini, Yunita Widyastuti, Cindy Elfira Boom, et al.
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 10, pp. 5075-5084
Open Access | Times Cited: 6

LGR6 protects against myocardial ischemia-reperfusion injury via suppressing necroptosis
Mengmeng Zhao, Zihui Zheng, Jianfang Liu, et al.
Redox Biology (2024) Vol. 78, pp. 103400-103400
Open Access | Times Cited: 2

Upregulation of miR-144-3p protects myocardial function from ischemia–reperfusion injury through inhibition of TMEM16A Ca2+-activated chloride channel
Guo‐Xun Yang, Xiao Tang, Ling Tan, et al.
Human Cell (2021) Vol. 34, Iss. 2, pp. 360-371
Closed Access | Times Cited: 14

Therapeutic potential of a single-dose melatonin in the attenuation of cardiac ischemia/reperfusion injury in prediabetic obese rats
Kodchanan Singhanat, Nattayaporn Apaijai, Natticha Sumneang, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Closed Access | Times Cited: 10

Necrostatin-1 reduces cardiac and mitochondrial dysfunction in prediabetic rats
Nattayaporn Apaijai, Kewarin Jinawong, Kodchanan Singhanat, et al.
Journal of Endocrinology (2021) Vol. 251, Iss. 1, pp. 27-39
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top